Marino Garcia in

Marino Garcia

Login to view DISC.
President & Chief Executive Officer, Board Member at Dianthus Therapeutics, Inc.
📍 New York, New York, United States

Marino Garcia is the President and CEO of Dianthus Therapeutics, leveraging over 25 years of experience in the pharmaceutical and biotech industries. His expertise spans corporate strategy, business development, and commercial leadership in rare disease and specialty markets. He holds an MBA from the Ivey Business School and is a Certified Licensing Professional.

His colleagues describe him as dynamic, articulate, and organized. They highlight his ability to learn quickly and his effectiveness in leading cross-functional teams and developing talent. He is known for inspiring loyalty and being focused on achieving goals.

He has a track record of executing major strategic transactions, including a key licensing deal for a complement inhibitor with Alexion Pharmaceuticals and leading the $583 million acquisition of EURAND.

Read the full overview →
Current Role
President & Chief Executive Officer, Board Member
Location
New York, New York, United States
Personality Overview

How Marino shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Marino cares about

Autoimmune Disease Therapies
As CEO of Dianthus, he is focused on developing next-generation, self-administered therapies for severe autoimmune conditions like Generalized Myasthenia Gravis (gMG) to reduce patient treatment burdens.
Biotech Corporate Strategy
He has held Chief Strategy Officer roles and focuses on building value for patients and shareholders by advancing clinical trials and seeking strategic growth opportunities for Dianthus.
+4 more topics Login to view topics
Career

Work history

11-2021
President & Chief Executive Officer, Board Member
Dianthus Therapeutics, Inc.
10-2018 - 10-2021
SVP, Corporate & Business Development
Zealand Pharma A/S
3-2016 - 9-2018
EVP, Chief Strategy Officer
Synergy
3-2014 - 3-2016
Senior Vice President Corporate Development
Synergy
2-2010 - 2-2014
Vice President, Global Business Development
Aptalis Pharma (formerly Axcan Pharma)
In the press

Media appearances

Dianthus Therapeutics, Inc. (DNTH) Phase 2 MaGic Data Investor Webcast Transcript. Featured in Seeking Alpha
See now
Education
1992 - 1994
MBA
Ivey Business School at University of Western Ontario
2012 - 2012
Strategic Negotiations
Harvard Business School
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Dianthus Therapeutics, Inc. Employees

Explore more public profiles from related professionals.

Ryan Savitz
Ryan Savitz
Chief Financial Officer & Chief Business Officer
Dianthus Therapeutics, Inc.
 Tom Chen
Tom Chen
Senior Director, Head of Drug Substance and MSAT
Dianthus Therapeutics, Inc.

More profiles

Discover additional public profiles from our index.

Lisa Marie Ardagna
Lisa Marie Ardagna
Head of People Operations
Ribbiot
AR
Arlene Ricker
Director of Retained Services
Corporate Research Associates LLC
 Demetrius Nunes
Demetrius Nunes
Country Manager | Senior Engineering Manager
DoorDash
 Johnathan Ransom
Johnathan Ransom
A cargo
Ransom & Moreno Landscaping
Unlock the full playbookSee exactly how to sell to Marino. Free, 10 seconds.